Primate Data on Tekmira Marburg Infection Drug Published | GenomeWeb

NEW YORK (GenomeWeb) – Tekmira Pharmaceuticals this week announced the publication of data showing that siRNAs targeting the Marburg virus and formulated with its proprietary lipid nanoparticles can completely protect non-human primates from infection.

The findings were published in Science Translational Medicine, and were previously presented by the company in April at the 6th International Symposium of Filoviruses.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.